News
Moderna COVID-19 vaccine, FDA
Digest more
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Moderna isn’t the only company that has been studying a two-in-one combination vaccine against both flu and Covid-19; Pfizer and BioNTech have been working on one, and Novavax, too.
In the Moderna trial, 90 of the first 95 participants to develop COVID-19 had received the placebo and only five the active vaccine, so it was 94.5% effective. Results from another 56 ...
Moderna Inc. jumped by 8.83 percent on Tuesday to close at $32.54 apiece as investor sentiment was boosted by a lawsuit filed ...
Moderna shares surged 9.5% amid legal backlash against vaccine policy changes. Will it be a turning point for MRNA which is ...
Intense throat pain is a key symptom of COVID-19 variant NB.1.8.1, referred to as "razor blade throat." Here's what to know.
Pfizer and Moderna will now include more information on the risk of myocarditis on their COVID-19 vaccine labels.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results